# Efficacy and Safety of Neosil on Chronic Effluvium

> **NCT03659201** · PHASE4 · COMPLETED · sponsor: **EMS** · enrollment: 232 (actual)

## Conditions studied

- Chronic Telogen Effluvium

## Interventions

- **DRUG:** Neosil complete
- **DRUG:** Pantogar
- **DRUG:** Neosil

## Key facts

- **NCT ID:** NCT03659201
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2019-06-04
- **Final completion:** 2020-03-30
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2020-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03659201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03659201, "Efficacy and Safety of Neosil on Chronic Effluvium". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03659201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*